Nemus Bioscience makes progress with cannabinoid-based glaucoma treatment

0 views
0%

Nemus Bioscience Inc (OTCMKTS:NMUS) had a chat with Christine Corrado from Proactive Investors at the MicroCap Conference in New York. Nemus is a …

From:
Date: December 26, 2020

Leave a Reply

Your email address will not be published. Required fields are marked *